InnoCare Pharma Limited (9969.HK) HKSE
14.74
+0.66(+4.69%)
Currency In HKD
- General
- Statistics
- Historical Data
- Profile
- Financials
14.74
+0.66(+4.69%)
Currency In HKD
| Market Cap | 19.47B |
| Enterprise Value | 14B |
| P/E Ratio | 35.81 |
| PEG Ratio | 0.06 |
| Price/Sales Ratio | 8.15 |
| Price/Book Ratio | 2.93 |
| Enterprise/Revenue | 5.83 |
| Enterprise/EBITDA | 23.9 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | December 31, 2025 |
| Profit Margin | 0.27 |
| Operating Margin | 0.23 |
| Return On Assets | 0.06 |
| Return On Equity | 0.09 |
| Revenue | 2.3B |
| Revenue/Share | 1.34 |
| Gross Profit | 2.01B |
| EBITDA | 555.89M |
| Net Income | 625.84M |
| Diluted EPS | 0.36 |
| Total Cash | 7.34B |
| Total Cash/Share | 4.16 |
| Total Debt | 1.61B |
| Total Debt/Equity | 0.21 |
| Current Ratio | 5.83 |
| Book Value Per Share | 4.56 |
| 52-Week Change | 40.11 |
| 52-Week High | 20.62 |
| 52-Week Low | 8.86 |
| Moving Average 50 Days | 13.22 |
| Moving Average 200 Days | 14.81 |
| Average Volume | 8.82M |
| Shares Outstanding | 1.49B |
| % Held by Institutions | N/A |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0.03 |
| Last Split Factor | N/A |
| Last Split Date | N/A |